mercredi 26 novembre 2014

Study unlocks basis of key immune protein's two-faced role

A long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system has been discovered by researchers. The interest in TIM-3 as a drug target stems largely from its inhibitory role, particularly in cancer. Scientists explain that if there were a way to block TIM-3 pharmacologically, it could unleash the immune system, freeing it to attack tumors.

Study unlocks basis of key immune protein's two-faced role

Aucun commentaire:

Enregistrer un commentaire